29.03.2012 • News

BioAmber Produces Bio-based 1,4-Butanediol

BioAmber has scaled up its hydrogenation catalyst technology under license from DuPont and converted multi-ton quantities of bio-succinic acid into 100% bio-based 1,4-butanediol (1,4-BDO), tetrahydrofuran (THF) and gamma-butyrolactone (GBL).

BioAmber believes the global addressable market for these products exceeds $4 billion, and that they are principally used to make polyesters, polyurethanes, spandex and biodegradable plastics.

Using bio-succinic acid made at its French facility as a starting material, BioAmber successfully completed a 1,4-BDO production campaign in collaboration with one of the world's leading commercial catalyst suppliers and a toll manufacturer possessing large-scale hydrogenation reactors and distillation columns.

"This is the culmination of two years of work and an important milestone in the development of our bio-based 1,4-BDO platform. We have been able to couple the DuPont catalyst technology with our bio-succinic acid production to manufacture high purity bio-based 1,4-BDO at demonstration scale," Jim Millis, BioAmber's Chief Technology Officer said. "We are developing an integrated plant engineering design that combines the production of bio-succinic acid and bio-based 1,4-BDO on a single site," he added.

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

most read